NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Hyperion Therapeutics, Inc. (NASDAQ: HPTX) (“Hyperion” or “the Company”) in connection with the sale of the Company to Horizon Pharma.
Click here to learn about the case: http://docs.wongesq.com/HPTX-Info-Request-Form-667. There is no cost or obligation to you.
Under the terms of the transaction, Hyperion shareholders will receive $46.00 in cash for each share of Hyperion stock they own. The investigation concerns whether the Board of Hyperion breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Horizon Pharma is underpaying for Hyperion shares.
If you own common stock in Hyperion and wish to obtain additional information, please contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/HPTX-Info-Request-Form-667.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002